Tammenoms Bakker Juliet

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -27% 8.2% 15.1%
Success rate 23% 68% 82%
Transactions
16 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 121%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Tammenoms Bakker Juliet's trades of CeriBell Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-16 2024-10-15
US CeriBell Inc (CBLL)
B Purchase
42,700 +5.0%
206.56
US$4,130,991 		42,700 +5.0% 206.56 US$4,130,991
2024-05-21 2024-05-17
US Rxsight Inc (RXST)
B Purchase
28,208 +12.4%
128.16
US$1,181,446 		28,208 +12.4% 128.16 US$1,181,446
2024-02-15 2024-02-14
US Rxsight Inc (RXST)
B Purchase
16,620 -21.5%
484.10
US$3,138,398 		16,620 -21.5% 484.10 US$3,138,398
2024-02-15 2024-02-12
US Rxsight Inc (RXST)
B Purchase
4,000 +18.3%
50.38
US$201,520 		4,000 +18.3% 50.38 US$201,520
2023-11-30 2023-11-29
US Rxsight Inc (RXST)
S Sale
349,245 -100.0%
29.77
US$10,398,665 		349,245 -100.0% 29.77 US$10,398,665
2023-11-30 2023-11-28
US Rxsight Inc (RXST)
S Sale
145,068 -29.3%
29.62
US$4,297,030 		145,068 -29.3% 29.62 US$4,297,030
2023-11-16 2023-11-15
US Rxsight Inc (RXST)
S Sale
400,000 -44.7%
27.20
US$10,878,160 		400,000 -44.7% 27.20 US$10,878,160
2023-11-16 2023-11-14
US Rxsight Inc (RXST)
S Sale
100,000 -10.1%
27.13
US$2,712,590 		100,000 -10.1% 27.13 US$2,712,590
2023-09-11 2023-09-11
US Rxsight Inc (RXST)
S Sale
2,950 -12.7%
30.01
US$88,525 		2,950 -12.7% 30.01 US$88,525
2023-09-11 2023-09-08
US Rxsight Inc (RXST)
S Sale
10,033 -30.2%
30.25
US$303,461 		10,033 -30.2% 30.25 US$303,461
2023-09-12 2023-09-07
US Rxsight Inc (RXST)
PrS Proposed sale
32,950
30.35
US$1,000,032 		32,950 30.35 US$1,000,032
2023-09-11 2023-09-07
US Rxsight Inc (RXST)
S Sale
19,967 -37.6%
30.10
US$600,983 		19,967 -37.6% 30.10 US$600,983
2023-09-07 2023-09-07
US Rxsight Inc (RXST)
PrS Proposed sale
32,950
30.35
US$1,000,032 		32,950 30.35 US$1,000,032
2023-08-28 2023-08-25
US Rxsight Inc (RXST)
S Sale
16,208 -23.4%
29.25
US$474,129 		16,208 -23.4% 29.25 US$474,129
2023-08-25 2023-08-25
US Rxsight Inc (RXST)
PrS Proposed sale
16,208
29.36
US$475,867 		16,208 29.36 US$475,867
2023-08-18 2023-08-18
US Rxsight Inc (RXST)
S Sale
14,651 -17.6%
29.07
US$425,877 		14,651 -17.6% 29.07 US$425,877
2023-08-18 2023-08-17
US Rxsight Inc (RXST)
S Sale
18,484 -18.2%
30.06
US$555,694 		18,484 -18.2% 30.06 US$555,694
2023-08-17 2023-08-17
US Rxsight Inc (RXST)
PrS Proposed sale
33,135
30.00
US$994,050 		33,135 30.00 US$994,050
2023-02-13 2023-02-10
US Rxsight Inc (RXST)
B Purchase
480,000 +96.0%
12.50
US$6,000,000 		480,000 +96.0% 12.50 US$6,000,000
2020-10-22 2020-10-20
US Eargo Inc (EAR)
B Purchase
233,333 +6.3%
18.00
US$4,199,994 		233,333 +6.3% 18.00 US$4,199,994
2020-09-22 2020-09-18
S Sale
9,167 -72.4%
42.67
US$391,119 		9,167 -72.4% 42.67 US$391,119
2020-08-18 2020-08-14
S Sale
2,393 -20.7%
43.22
US$103,422 		2,393 -20.7% 43.22 US$103,422